Matthias Saar

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Benign Prostatic Hyperplasia

Radical Prostatectomy

Top Venues

Diagnostics (Basel, Switzerland)

BJU international

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Hoffmann, Thomas Frank Ermler, Felix Hoffmann, Radu Alexa, Jennifer Kranz, Nathalie Steinke, Sophie Leypold, Nadine Therese Gaisa, Matthias Saar
Therapeutic and Diagnostic Potential of Folic Acid Receptors and Glycosylphosphatidylinositol (GPI) Transamidase in Prostate Cancer. Cancers 16 (11) (2024)
Marco Hoffmann, Thomas Frank Ermler, Felix Hoffmann, Radu Alexa, Jennifer Kranz, Nathalie Steinke, Sophie Leypold, Nadine Therese Gaisa, Matthias Saar
Therapeutic and Diagnostic Potential of Folic Acid Receptors and Glycosylphosphatidylinositol (GPI) Transamidase in Prostate Cancer. Cancers 16 (11) (2024)
Fabian P Stangl, Laila Schneidewind, Florian M E Wagenlehner, Daniela Schultz-Lampel, Kaven Baeßler, Gert Naumann, Sandra Mühlstädt, Petra Anheuser, Susanne Winkelhog-Gran, Matthias Saar, Tanja Hüsch, Jennifer Kranz
Do or Don't: Results of a Multinational Survey on Antibiotic Prophylaxis in Urodynamics. Antibiotics (Basel, Switzerland) 12 (7) (2023)
Fidelis Andrea Flockerzi, Johannes Hohneck, Matthias Saar, Rainer Maria Bohle, Phillip Rolf Stahl
THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Fidelis Andrea Flockerzi, Johannes Hohneck, Matthias Saar, Rainer Maria Bohle, Phillip Rolf Stahl
THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Fidelis Andrea Flockerzi, Johannes Hohneck, Matthias Saar, Rainer Maria Bohle, Phillip Rolf Stahl
THSD7A Positivity Is Associated with High Expression of FAK in Prostate Cancer. Diagnostics (Basel, Switzerland) 13 (2) (2023)
Fidelis Andrea Flockerzi, Johannes Hohneck, Matthias Saar, Rainer Maria Bohle, Phillip Rolf Stahl
SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis. Diagnostics (Basel, Switzerland) 13 (13) (2023)
Carsten-Henning Ohlmann, Matthias Saar, Laura-Christin Pierchalla, Miran Zangana, Alena Bonaventura, Michael Stöckle, Stefan Siemer, Julia Heinzelbecker
Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours. Scientific reports 11 (1) (2021)
Christina Niklas, Matthias Saar, Alessandro Nini, Johannes Linxweiler, Stefan Siemer, Kerstin Junker, Michael Stoeckle
Can local treatment prolong the sensitivity of metastatic prostate cancer to androgen deprivation or even prevent castration resistance? World journal of urology 39 (9) (2021)
Ahmed A Hussein, Ahmed S Elsayed, Naif A Aldhaam, Zhe Jing, James O Peabody, Carl J Wijburg, Andrew Wagner, Abdullan Erdem Canda, Mohammad Shamim Khan, Douglas Scherr, Francis Schanne, Thomas J Maatman, Eric Kim, Alexandre Mottrie, Ahmed Aboumohamed, Franco Gaboardi, Giovannalberto Pini, Jihad Kaouk, Bertram Yuh, Koon Ho Rha, Ashok Kumar Hemal, Joan Palou Redorta, Ketan Badani, Matthias Saar, Michael Stockle, Lee Richstone, Morgan Roupret, Derya Balbay, Prokar Dasgupta, Mani Menon, Khurshid A Guru
A comparative propensity score-matched analysis of perioperative outcomes of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. BJU international 126 (2) (2020)
Turkan Hajili, Carsten-Henning Ohlmann, Johannes Linxweiler, Christina Niklas, Martin Janssen, Stefan Siemer, Michael Stoeckle, Matthias Saar
Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up. BJU international 123 (1) (2018)
Johannes Linxweiler, Markus Hammer, Stefanie Muhs, Moritz Kohn, Alexej Pryalukhin, Christian Veith, Rainer M Bohle, Michael Stöckle, Kerstin Junker, Matthias Saar
Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer. Journal of cancer research and clinical oncology 145 (3) (2018)